$2.72 Billion in Sales Expected for Mylan NV (MYL) This Quarter

Wall Street analysts predict that Mylan NV (NASDAQ:MYL) will report sales of $2.72 billion for the current quarter, according to Zacks. Four analysts have made estimates for Mylan’s earnings. The lowest sales estimate is $2.60 billion and the highest is $2.81 billion. Mylan reported sales of $2.68 billion during the same quarter last year, which indicates a positive year-over-year growth rate of 1.5%. The firm is expected to report its next quarterly earnings results on Wednesday, May 8th.

According to Zacks, analysts expect that Mylan will report full-year sales of $11.92 billion for the current fiscal year, with estimates ranging from $11.83 billion to $12.01 billion. For the next year, analysts forecast that the firm will post sales of $12.55 billion, with estimates ranging from $12.42 billion to $12.85 billion. Zacks Investment Research’s sales calculations are a mean average based on a survey of research firms that follow Mylan.

Mylan (NASDAQ:MYL) last issued its quarterly earnings data on Tuesday, February 26th. The company reported $1.30 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.36 by ($0.06). Mylan had a net margin of 3.08% and a return on equity of 19.06%. The company had revenue of $3.04 billion for the quarter, compared to analysts’ expectations of $3.10 billion. During the same quarter last year, the company earned $1.43 earnings per share. The company’s revenue for the quarter was down 4.8% on a year-over-year basis.



A number of brokerages have issued reports on MYL. UBS Group restated a “neutral” rating and set a $31.00 price objective on shares of Mylan in a research report on Thursday, March 7th. Zacks Investment Research downgraded Mylan from a “hold” rating to a “strong sell” rating in a research report on Wednesday, March 6th. Credit Suisse Group restated a “buy” rating and set a $37.00 price objective on shares of Mylan in a research report on Wednesday, March 6th. Morgan Stanley upgraded Mylan from an “equal weight” rating to an “overweight” rating and set a $35.00 price objective on the stock in a research report on Wednesday, March 6th. They noted that the move was a valuation call. Finally, Wells Fargo & Co decreased their price objective on Mylan from $40.00 to $33.00 and set an “outperform” rating on the stock in a research report on Wednesday, February 27th. Three analysts have rated the stock with a sell rating, five have given a hold rating and fourteen have issued a buy rating to the company. Mylan currently has a consensus rating of “Buy” and an average price target of $40.72.

MYL stock traded up $0.09 during midday trading on Friday, reaching $28.09. 9,701,359 shares of the company traded hands, compared to its average volume of 5,572,629. Mylan has a 52-week low of $26.00 and a 52-week high of $42.50. The company has a debt-to-equity ratio of 1.17, a current ratio of 1.39 and a quick ratio of 0.83. The company has a market cap of $14.49 billion, a PE ratio of 6.13, a price-to-earnings-growth ratio of 1.15 and a beta of 1.47.

In related news, insider Paul Campbell sold 11,533 shares of the stock in a transaction that occurred on Monday, March 4th. The stock was sold at an average price of $27.50, for a total value of $317,157.50. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website. 0.81% of the stock is owned by corporate insiders.

A number of hedge funds and other institutional investors have recently made changes to their positions in MYL. Kinneret Advisory LLC acquired a new position in Mylan during the 4th quarter worth $71,000. First Hawaiian Bank grew its stake in Mylan by 560.4% in the 4th quarter. First Hawaiian Bank now owns 2,886 shares of the company’s stock valued at $79,000 after purchasing an additional 2,449 shares during the period. NuWave Investment Management LLC grew its stake in Mylan by 18.1% in the 4th quarter. NuWave Investment Management LLC now owns 3,136 shares of the company’s stock valued at $86,000 after purchasing an additional 480 shares during the period. FNY Investment Advisers LLC grew its stake in Mylan by 42.8% in the 4th quarter. FNY Investment Advisers LLC now owns 3,300 shares of the company’s stock valued at $90,000 after purchasing an additional 989 shares during the period. Finally, Fort L.P. bought a new position in Mylan in the 4th quarter valued at $92,000. 83.01% of the stock is currently owned by institutional investors and hedge funds.

Mylan Company Profile

Mylan N.V., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic, brand name, and over-the-counter (OTC) products worldwide. The company operates through three segments: North America, Europe, and Rest of World. It offers pharmaceutical products in tablet, capsule, injectable, transdermal patch, gel, nebulized, and cream or ointment forms.

Read More: What is the price-to-earnings growth (PEG) ratio?

Get a free copy of the Zacks research report on Mylan (MYL)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Mylan (NASDAQ:MYL)

Receive News & Ratings for Mylan Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mylan and related companies with MarketBeat.com's FREE daily email newsletter.